The difference of free light chains as a predictor of kidney damage in patients with Multiple Myeloma
Background: Multiple myeloma (MM) is a malignant neoplasm characterized by the clonal expansion of plasma cells that can release monoclonal immunoglobulins (monoclonal component) or part of theme. Since 2001, the k and λ serum free light chains (sFLC) evaluation and their ratio (rFLC) have made up t...
Saved in:
| Main Authors: | Salvatrice Mancuso, Melania Carlisi, Nicola Serra, Mariano Sardo, Giuseppe Bertuglia, Emanuela Pappalardo, Sergio Siragusa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Milano University Press
2020-06-01
|
| Series: | Epidemiology, Biostatistics and Public Health |
| Online Access: | https://ebph.it/article/view/13292 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Calculated haemorheological profile and laboratory parameters in new diagnosed multiple myeloma patients: retrospective analysis according to survival
by: Melania Carlisi, et al.
Published: (2024-11-01) -
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL
by: Vincenzo Accurso, et al.
Published: (2020-01-01) -
Multiple myeloma and light-chain amyloidosis: a rare presentation
by: carmenza Liliana Sandoval, et al.
Published: (2018-07-01) -
Serum Free Light Chain Only Myeloma with Cytoplasmic IgM
by: Hideaki Ebana, et al.
Published: (2014-01-01) -
Light-Chain Myeloma Presented as Osseus Tumors: A Case Report
by: Shengmin Huang MD, et al.
Published: (2024-12-01)